Home » Topics » BioWorld Science

BioWorld Science
RSS

Dynavax, University of Queensland and CEPI collaborate to develop COVID-19 vaccine

March 3, 2020

Nitto Denko initiates phase II study in Japan with ND-L02-s0201 for IPF

March 3, 2020

IPA enters AI collaboration to develop therapeutics and vaccines against SARS-CoV-2 coronavirus

March 3, 2020

Increasing immune activity improves autoimmunity

March 3, 2020

New phase III trials evaluate switch to doravirine/islatravir in HIV patients on other regimens

March 3, 2020

First-in-human data for EHP-101

March 3, 2020

Finding the silent majority

March 3, 2020

BCHT's live attenuated influenza virus vaccine receives approval in China

March 3, 2020

Favipiravir studied in clinical trials in China for COVID-19

March 2, 2020

Medivir announces phase Ia findings with MIV-818 in liver cancer

March 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...